Paroxetine vs Quetiapine and Hypercapnia, SARS-CoV-2 Vaccination and COVID-19 Outcomes, USPSTF Recommendation on Anxiety in Children and Adolescents, and more
Editor’s Summary by Kirsten Bibbins-Domingo, PhD, MD, MAS, Editor in Chief of JAMA, the Journal of the American Medical Association, for the October 11, 2022, issue. (Source: JAMA: This Week's Audio Commentary)
Source: JAMA: This Week's Audio Commentary - October 11, 2022 Category: General Medicine Authors: JAMA Network Source Type: podcasts
Social Anxiety Disorder and Phased Treatment
This study is being conducted with qualified individuals 18 – 65 years old suffering from social anxiety disorder. The study explores how the FDA-approved medication paroxetine (Paxil) affects coping behaviors men and women typically use to deal with anxiety in social situations. Participants will be asked to attend 10 sessions over the course of 22 weeks, as well as two follow-up visits at 3 and 6 months following the medication phase. 80 subjects will be recruited – 40 at the Medical University of South Carolina and 40 at the University of Minnesota. (Source: MUSC Mental Health Podcast)
Source: MUSC Mental Health Podcast - April 6, 2014 Category: Psychiatry Authors: Medical University of South Carolina Source Type: podcasts
Experiment shows medical doctors to be glorified drug dealers, easily manipulated by drug companies
Heres some fascinating news in the world of medicine that really shows the drug racket -- the huge prescription drug scam taking place in this country today. Researchers sent a group of people who said they saw the drug Paxil in a TV advertisement into doctors offices. Many of these patients didn't even show signs of depression but when they named the drug 50 percent were diagnosed as having depression and 55 percent were given a prescription for the exact prescription drug they named. (Source: Health Ranger Report)
Source: Health Ranger Report - April 6, 2014 Category: Consumer Health News Source Type: podcasts
First FDA-Approved Nonhormonal Drug for Hot Flashes
Andrew Kaunitz discusses paroxetine mesylate, the first approved nonhormonal option for treating vasomotor symptoms. (Source: Medscape Nurses Podcast)
Source: Medscape Nurses Podcast - July 1, 2013 Category: Nursing Authors: Medscape Source Type: podcasts
First FDA-Approved Nonhormonal Drug for Hot Flashes
Andrew Kaunitz discusses paroxetine mesylate, the first approved nonhormonal option for treating vasomotor symptoms. (Source: Medscape Pharmacists Podcast)
Source: Medscape Pharmacists Podcast - July 1, 2013 Category: Drugs & Pharmacology Authors: Medscape Source Type: podcasts
Paxil Made Me Do It!
Today I comment on two cases in which Paxil, an SSRI, was seen as being the cause or contributor to a case of embezzlement and a case of murder/suicide. (Source: The Shrink Is In)
Source: The Shrink Is In - November 27, 2006 Category: Psychiatrists and Psychologists Authors: DrGurr Source Type: podcasts
